Brightspec provides analytical chemistry solutions using FT-MRR spectroscopy, a new commercial technique for direct.
BrightSpec has raised $18.4M in total funding. The most recent round was Series C. The last funding was announced in December 2022.
BrightSpec's investors include National Science Foundation, Arboretum Ventures, Genoa Ventures, Felton Group LLC, CAV Angels.
BrightSpec is headquartered in Charlottesville, United States.
Brightspec provides analytical chemistry solutions using FT-MRR spectroscopy, a new commercial technique for direct.
BrightSpec is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BrightSpec — Funding & Investors." VCBacked, December 14, 2022, https://www.vcbacked.co/company/brightspec. Accessed August 13, 2026.
VCBacked. (2022). BrightSpec — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/brightspec
{{cite web |title=BrightSpec — Funding & Investors |url=https://www.vcbacked.co/company/brightspec |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated